SVP, Medical Affairs @ (January 2015 - January 2017)
VP, Medical Affairs @ Synta Pharmaceuticals (January 2012 - January 2015)
VP Medical Affairs, and VP R and D Strategy and Alliances @ Allos Therapeutics (January 2009 - January 2011)
Oncology Team Leader @ (January 2009 - January 2009)
VP Medical Affairs @ ImClone Systems and Eli Lilly (January 2005 - January 2009)
Executive Director, Head of Oncology Medical Affairs @ (January 2003 - January 2005)
Head of Oncology Medical Affairs, USA @ (January 1998 - January 2003)
Assoc Professor (tenured) and Lead Investigator, UVA Cancer Center @ (January 1995 - January 1998)
Section Chief, Differentiation Control, Division of Cancer Therapy @ (January 1990 - January 1995)
Assistant Professor, Medical School @ Uniformed Services University of the Health Sciences (USUHS) (January 1982 - January 1990)
Dvorit Samid Education
The Catholic University of America
PhD
1980-1985
The Hebrew University of Jerusalem
BSc
Technion - Israel Institute of Technology
Graduate studies
Dvorit Samid Skills
Drug Development
Pharmaceutical Industry
Medical Affairs
Strategic Partnerships
Clinical Trials
Medical Communications
Oncology
Metabolic Syndrome
Inflammation
Clinical Development
Hematology
Medical Education
Informatics
Medicine
Cancer
Immunology
Life Sciences
Biotechnology
Lifesciences
Clinical Research
Microsoft Office
Customer Service
Management
Project Management
Hospitals
Team Leadership
Dvorit Samid Summary
Dvorit Samid, based in United States, is currently a EVP, Medical Affairs at Aardvark Therapeutics. Dvorit Samid brings experience from previous roles at Numenos AI, Rothbart Group - Oncology, Consulting., NantKwest and Synta Pharmaceuticals. Dvorit Samid holds a 1980 - 1985 PhD @ The Catholic University of America. With a robust skill set that includes Drug Development, Pharmaceutical Industry, Medical Affairs, Strategic Partnerships, Clinical Trials and more. Dvorit Samid has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Dvorit Samid?
Find contact details for 700 million professionals.